Diseases Archives - Page 26 of 45 - Pharma Journalist

FDA sanctions breakthrough treatment for specific kind of Prostate Cancer

J&J Pharmaceuticals announce approval of ERLEADA by FDA for NM-CRPC patients

Mallinckrodt affirms enlisting of first patient for ExpressGraft C9T1 Phase 1 Study

FDA accepts Ortho Dermatologics JEMDEL for Plaque Psoriasis Treatment

Amgen’s BLINCYTO sBLA to be assessed by FDA for treating MRD

FDA paves way for marketing of Viz.AI Contact application

Trovagene declares activation of 2 supplementary Clinical Trial sites to conduct Phase 1b/2 Study

Astro declares positive results of phase II OPTIMA Clinical trial

Cytobank associates with FDA to enhance Immunotherapy Development

Quidel seeks 510 (k) Clearance for QuickVue Influenza A+B Test complying FDA’s Class II RIDT Requirements